Will 2023 be the year we see some major shifts in access and attitudes towards cannabis? With help from experts, we lay out our predictions for the year ahead. 2022 saw some major developments for cannabis across the globe. The collective value of the CBD, medical [...]
For U.S. venture capitalists (VCs), the burgeoning European cannabis market provides opportunities to break into the industry on the heels of adult-use legalization. Germany has set its sights on implementing a recreational market by 2024, and the country, along with several other European Union (EU) countries–Malta [...]
On December 29 just before the end of 2022, New York officially launched legal adult use sales in the state, but at only one location. The nonprofit dispensary Housing Works Cannabis Co. held a grand opening party complete with music, speeches from politicians and regulators and [...]
Cannabis research continues to flourish across the globe, with a record number of scientific papers published in 2022. Hundreds more studies were published on cannabis in 2022 than in the years previously, according to figures collected by the US advocacy group NORML. Campaigners for wider access [...]
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
